2010 Focused Update of ESC Guidelines on device therapy in heart failure
about
The use of imaging for electrophysiological and devices procedures: a report from the first European Heart Rhythm Association Policy Conference, jointly organized with the European Association of Cardiovascular Imaging (EACVI), the Council of CardioWhy QRS Duration Should Be Replaced by Better Measures of Electrical Activation to Improve Patient Selection for Cardiac Resynchronization TherapyPalliative care for those with heart failure: nurses' knowledge, attitude, and preparedness to practice.Analysis of endocardial acceleration during intraoperative optimization of cardiac resynchronization therapy.Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian RegistryLong-term outcomes after event-free cardioverter defibrillator implantation: comparison between patients discharged within 24 h and routinely hospitalized patients in the German DEVICE registry.Endoplasmic reticulum stress induces different molecular structural alterations in human dilated and ischemic cardiomyopathy.New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association.Effect of cardiac resynchronization therapy and implantable cardioverter defibrillator on quality of life in patients with heart failure: a meta-analysis.Sex- and gender-specific research priorities for the emergency management of heart failure and acute arrhythmia: proceedings from the 2014 Academic Emergency Medicine Consensus Conference Cardiovascular Research Workgroup.Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy.Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Echocardiographic assessment of right ventricular function in responders and non-responders to cardiac resynchronization therapyRationale and design of the health economics evaluation registry for remote follow-up: TARIFFAtrioventricular and ventricular-to-ventricular programming in patients with cardiac resynchronization therapy: results from ALTITUDEAtrial fibrillation in patients with heart failure: Role of catheter ablation therapies.First clinical evaluation of an atrial haemodynamic sensor lead for automatic optimization of cardiac resynchronization therapy.Transcriptomic profiling of the four adenosine receptors in human leukocytes of heart failure patients.The role of echocardiography in quantification of left ventricular dyssynchrony: state of the art and future directions.Clinical, laboratory, and pacing predictors of CRT response.Adverse effects of long-term right ventricular apical pacing and identification of patients at risk of atrial fibrillation and heart failure.Cardiac resynchronization and atrial fibrillation: what's new?2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management.Can cardiac resynchronization therapy improve cognitive function? A systematic review.Effects of atrioventricular nodal ablation on permanent atrial fibrillation patients with cardiac resynchronization therapy: a systematic review and meta-analysis.Detection and discrimination of tachycardia in ICDs manufactured by St. Jude Medical.Pivotal trials of cardiac resynchronization therapy: evolution to therapy in mild heart failure.Response to cardiac resynchronization therapy: the muscular metabolic pathway.Fragmented QRS as a Predictor of Appropriate Implantable Cardioverter-defibrillator Therapy.A 128-slice CT scanner helpful in localising coronary sinus ostium during CRT-D implantation - case report.Ventricular resynchronization therapy by direct His-bundle pacing using an internal cardioverter defibrillator.The association between ICD interventions and mortality is independent of their modality: clinical implications.Left ventricular dyssynchrony predicts clinical response to CRT - a long-term follow-up single-center prospective observational cohort study.Ranolazine maintained sinus rhythm in a patient with refractory symptomatic atrial fibrillation.Anatomical factors involved in difficult cardiac resynchronization therapy procedure: a non-invasive study using dual-source 64-multi-slice computed tomography.Pre- and intra-procedural predictors of reverse remodeling after cardiac resynchronization therapy: an MRI study.Electrical storm and heart failure worsening in implantable cardiac defibrillator patients.Advances in Cardiovascular Health in Women over the Past Decade: Guideline Recommendations for Practice.Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.European cardiac resynchronization therapy survey II: rationale and design.
P2860
Q26861465-17CCE204-784F-4EB9-9FE2-16A2DCDC67FCQ28074580-6A08702A-EF74-459F-8EA2-2C6F69FA1D3EQ30217460-23FDD12D-002D-4F88-BE10-E55F528B23C9Q30443343-C99C0A2B-09D1-4274-AF72-C2B1FD6F2F9CQ30594176-ECAC65D9-B369-4058-A5DD-E733C9C40ACAQ33167353-4515DC54-4F7E-4A81-8210-E64B2BC0758DQ34200257-36218B3D-8D70-43F1-93E5-D3C09D3EF14FQ34387086-C38645F9-F8B2-49B3-A093-233FE7CE357BQ34459001-BEFE1B41-B0B0-424E-B4FA-D2DED89B953DQ34836591-0F4DA2A2-8AF9-4373-9F83-24961738127FQ35555062-48310817-C809-40FE-AC9F-F91995066A8CQ35797623-D5B2A7D0-9361-46D5-BF88-E725DC93339FQ35992118-7BD04B8F-0E8A-442B-A4FA-80F5A41559A6Q36351829-B2F82031-20B3-4684-932D-C719A59FAC46Q36695666-09D0BEA2-27B4-4E22-AE6B-380EE5350F3EQ36768493-0FEDAC8A-C1FB-4504-B197-695A2C596C88Q36935341-D6DAC25D-4064-43BD-98A4-E13947FF580CQ37044096-B3BBFE08-3C2F-4F59-BBB0-181A9F64C819Q37957537-A9B320C3-9D05-45CD-9F78-FDF6110F87A1Q37987835-4B99F37E-9104-424C-8986-F1FD0B84C570Q37997450-A6FC6EF6-C5F5-4DD0-B83C-E297505ADEFBQ38007999-01B6D106-D284-473E-860E-711AA12A0530Q38038846-72F6B603-3F43-4304-B8D2-0E498FECC497Q38174131-31EB4BE1-424F-4C77-AFEF-A6E7D5A7E3A6Q38243233-B7BD99A7-3DD4-4814-9F62-52AE8FBA4CC3Q38948953-A83FD57C-B0BC-47B1-B568-299BEBAE33C9Q39775680-E6D52A22-2820-404D-88B7-C59D9A21783CQ41488484-306694D3-3DDC-4190-92C2-C36F265DAE45Q41764473-37AB9448-CC72-4811-B336-C5FE11C70B89Q41875463-4FDEC4D2-23D7-4E60-84C1-5872A108D541Q43563300-DEBC308A-9E5C-4101-87F7-946CC11A7C14Q43638454-484E3C45-07E2-404C-ADD4-FD86A78F921EQ44017487-E3981D73-C346-4414-8565-E0DA20C055F0Q44891976-018163B0-46A4-4875-9468-7A1731058BE9Q45089854-41650FD7-5869-44C8-8A97-B8AE05AD86E4Q45141369-9846BFB2-4FD5-4374-98CF-1CB3D29892A6Q46398248-EA3A98D6-664A-484F-802A-C252C49AC601Q46481896-7DCB96E8-2248-4089-AF06-1B19D41EA701Q46920444-8B2FA473-F51F-4C82-9606-1A886B2CE97BQ46977215-DEF4E3F9-DCD9-43E7-B9A4-D765EA230BF5
P2860
2010 Focused Update of ESC Guidelines on device therapy in heart failure
description
im November 2010 veröffentlichter wissenschaftlicher Artikel
@de
наукова стаття, опублікована в листопаді 2010
@uk
name
2010 Focused Update of ESC Guidelines on device therapy in heart failure
@en
type
label
2010 Focused Update of ESC Guidelines on device therapy in heart failure
@en
prefLabel
2010 Focused Update of ESC Guidelines on device therapy in heart failure
@en
P2093
P2860
P50
P356
P1433
P1476
2010 Focused Update of ESC Guidelines on device therapy in heart failure
@en
P2093
A. John Camm
Alec Vahanian
Angelo Auricchio
Arno W. Hoes
Bela Merkely
Bogdan A. Popescu
Carsten W. Israel
Jean-Claude Daubert
Jean-Jacques Blanc
Maurizio Gasparini
P2860
P304
P356
10.1093/EUROPACE/EUQ392
P50
P577
2010-11-01T00:00:00Z